|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Medicine (Drs. Tsang, Chin-wan Fung, Lam, Mr. Leung, and Ms. Chan), Anatomy (Dr. Tipoe), and Diagnostic Radiology (Dr. Ooi), The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China.
Correspondence to: Kenneth W. Tsang, MD, FCCP, Associate Professor and Honorary Consultant Physician, University Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Rd, Hong Kong SAR, China; e-mail: kwttsang{at}hkucc.hku.hk
Study objectives: Although there has been tremendous attention on endogenous nitric oxide (NO) production in many respiratory and systemic diseases, little is known on NO production in bronchiectasis.
Design and setting: We determined exhaled and sputum NO levels in 109 patients with stable bronchiectasis (71 women; mean ± SD age, 58.2 ± 14.1 years) and 78 control subjects (39 women; mean age, 56.7 ± 12.1 years) by using an automatic chemiluminescence analyzer.
Measurements and results: There was no significant difference in exhaled NO between patients with bronchiectasis and control subjects (p = 0.11). Bronchiectasis patients with Pseudomonas aeruginosa infection had a significantly lower exhaled, but not sputum, NO levels than their counterparts and control subjects (p = 0.04 and p = 0.009, respectively). Exhaled NO correlated with 24-h sputum volume in P aeruginosa-infected patients (r = - 0.36; p = 0.002). After adjustment for sputum volume and number of bronchiectatic lung lobes, P aeruginosa-infected patients still had lower exhaled NO levels than their counterparts (p = 0.01). There was no correlation between exhaled NO with FEV1, FVC, and the number of bronchiectatic lung lobes (p > 0.05). Sputum NO levels were not different between patients and control subjects (p = 0.64), and had no correlation with clinical parameters.
Conclusion: Exhaled NO appears to be reduced among bronchiectasis patients with P aeruginosa infection independent of other clinical parameters, and further studies on the potential mechanisms and pathogenetic implications of this reduction should be pursued.
Key Words: assessment bronchiectasis nitric oxide
This article has been cited by other articles:
![]() |
K. G. Lim and C. Mottram The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice Chest, May 1, 2008; 133(5): 1232 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005 Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 912 - 930. [Full Text] [PDF] |
||||
![]() |
W. J. Jordan, P. A. Brookes, R. M. Szydlo, J. M. Goldman, R. I. Lechler, and M. A. Ritter IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation Blood, January 15, 2004; 103(2): 717 - 724. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |